MWG Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.91M | Sell |
1,008,116
-1
| -0% | -$9 | 17.17% | 2 |
|
|
2025
Q1 | $10.8M | Hold |
1,008,117
| – | – | 18.48% | 2 |
|
|
2024
Q4 | $12.9M | Hold |
1,008,117
| – | – | 17.35% | 2 |
|
|
2024
Q3 | $27.8M | Hold |
1,008,117
| – | – | 30.81% | 2 |
|
|
2024
Q2 | $29.2M | Hold |
1,008,117
| – | – | 31.93% | 2 |
|
|
2024
Q1 | $45M | Hold |
1,008,117
| – | – | 33.29% | 2 |
|
|
2023
Q4 | $39.1M | Hold |
1,008,117
| – | – | 32.9% | 2 |
|
|
2023
Q3 | $29.6M | Hold |
1,008,117
| – | – | 28.73% | 2 |
|
|
2023
Q2 | $64.1M | Hold |
1,008,117
| – | – | 38.79% | 2 |
|
|
2023
Q1 | $47.6M | Hold |
1,008,117
| – | – | 33.5% | 2 |
|
|
2022
Q4 | $70M | Hold |
1,008,117
| – | – | 35.72% | 2 |
|
|
2022
Q3 | $148M | Hold |
1,008,117
| – | – | 56.93% | 1 |
|
|
2022
Q2 | $131M | Hold |
1,008,117
| – | – | 59.13% | 1 |
|
|
2022
Q1 | $102M | Hold |
1,008,117
| – | – | 43.09% | 2 |
|
|
2021
Q4 | $156M | Sell |
1,008,117
-6,809
| -0.7% | -$1.05M | 45.49% | 2 |
|
|
2021
Q3 | $300M | Sell |
1,014,926
-1,536
| -0.2% | -$455K | 36.43% | 1 |
|
|
2021
Q2 | $330M | Buy |
+1,016,462
| New | +$330M | 32.44% | 2 |
|